Price Alert

ArriVent BioPharma Inc. C... (AVBP)

NASDAQ: AVBP · Real-Time Price · USD

19.84

1.01 (5.36%)

At close: Oct 03, 2025, 3:59 PM

19.84

0.00%

After-hours: Oct 03, 2025, 04:04 PM EDT

ArriVent BioPharma Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-80.49M	-69.33M	-36.91M	-51.61M
Depreciation & Amortization	n/a	n/a	n/a	n/a
Stock-Based Compensation	3.21M	895.00	424K	66.67K
Other Working Capital	7.82M	11.22M	-9.95M	-4.23M
Other Non-Cash Items	n/a	1.38K	-2.38M	42.67M
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	7.07M	12.6M	-7.15M	-3.94M
Operating Cash Flow	-70.21M	-55.84M	-43.63M	-12.59M
Capital Expenditures	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	-194.16M	-25M	n/a	n/a
Sales Maturities Of Investments	1.7M	25M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-40M
Investing Cash Flow	-192.47M	n/a	n/a	-40M
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	631K	42.86K	15K	119.82M
Financial Cash Flow	186.58M	42.86M	169.72M	89.87M
Net Cash Flow	-76.1M	-12.98M	126.09M	37.28M
Free Cash Flow	-70.21M	-55.84M	-43.63M	-12.59M